Teva Pharmaceuticals

At Teva, we are committed to advancing healthcare through innovation, research, and strategic collaboration. Recently, Chris Fox, Executive Vice President of U.S. Commercial, and Eric A. Hughes, MD, PhD, Executive Vice President of Global R&D and Chief Medical Officer, participated in an in-depth discussion with Arsalan Arif of Endpoints News on the exciting developments driving the future of medicine and Teva’s commitment to the discovery of modern therapies. We invite you to watch the full recording to gain valuable insights into how Teva is positioned for continued growth in 2025 and beyond by investing in long-term innovation while addressing the immediate needs of patients today. https://ow.ly/glEc50Vlq3U #TevaPharm #WeAreAllInForBetterHealth #PivotToGrowth

Raňajky s inšpiráciou! 🌸 Včerajšie ráno bolo výnimočné – nielen vďaka skvelým raňajkám, ale aj preto, že sme spojili túto chvíľu s oslavou Medzinárodného dňa žien. Súčasťou podujatia bola pútavá prednáška o rozmanitosti významov farieb, ktorú nám priniesla andrea ziegler. Včera to nebolo len o oslavách, ale aj o otvorenej diskusii, rešpekte a uznaní. Pretože skutočná podpora žien nie je o jednom dni v roku – je o každodenných rozhodnutiach, príležitostiach a férovom prístupe. Ďakujeme všetkým kolegyniam a kolegom, ktorí prišli, zdieľali svoje myšlienky a prispeli k vytvoreniu takej skvelej atmosféry. #MDŽ #ŽenyVPráci #Inšpirácia

Got away from my spreadsheets for a day and visited the Henderson Behavioral Health Community Mental Health Center and its Crisis Stabilization Unit treating psychiatric patients in Florida. I gained firsthand insights as nurse practitioners Sharon Sarig and Marcia Binion shared the daily dilemmas of schizophrenia patient care and got acquainted with Tardive Dyskinesia therapies with the kind help of nurse practitioner Jessica M. DNP, APRN, PMHNP-BC. This experience not only highlighted the importance of aligning our financial strategies with clinical needs but also underscored our commitment to delivering the best available treatments. Our final stop for the day was Passageway Residence of Dade County Adult Mental Health, Florida's largest forensic psychiatric inpatient facility, extending supervised treatment to individuals with severe and persistent mental illnesses involved in the criminal justice system. Dr. ilan melnick shared information about their truly remarkable success in achieving a zero recidivism among individuals with insanity or schizophrenia diagnoses. I gained firsthand insights into the daily dilemmas of patient care, reinforcing the profound connection between financial decisions and patient outcomes. This experience not only highlighted the importance of aligning our financial strategies with clinical needs but also underscored our commitment to delivering the best available treatments. It was an eye-opening reminder that behind all those numbers we crunch daily, there are real people with unique medical needs, and understanding their journey is key to our success. A heartfelt thank you to Teva Pharmaceuticals USA colleagues Jon Miller and Jill (Shafranek) Brownley, for welcoming me into your workday. Your passion and commitment drive our success, and I'm grateful for the opportunity to get to know such talented individuals. Chris Fox Dell Faulkingham #WeAreAllInForBetterHealth #TevaUS #Neurology #Schizophrenia #MovementDisorders #MentalHealth #TardiveDyskinesia #HealthcareInnovation

What are biologics and biosimilars, and how is Teva shaping the future in this field? 💊 #Biologics are advanced medicines derived from living cells or organisms, offering the potential for targeted, personalized treatments that open up new possibilities for patient care. 💊 #Biosimilars, on the other hand, are biological medicines that closely resemble already approved biologics, providing more affordable and accessible treatment options. At Teva, we're not only developing innovative biologic drugs, but also investing in biosimilars as part of our Pivot to Growth strategy. A focus on biosimilars is also a natural progression for Teva, following its role in the development of the generic medicine industry over the past 40 years, combining a strength in generics with a knowledge of innovative medicine. As a global leader in pharmaceuticals and as an integral part of its Pivot to Growth strategy, Teva is making a commitment to the emerging biosimilar market. Currently, Teva has 11 innovative assets and 16 biosimilars in its pipeline. Dive deeper into Teva's pioneering work: https://ow.ly/VENs50ViRpT #Tevapharm

Every day in our labs, our scientists and physicians pour their passion into advancing medicine. Scientists, we want to know: what drives you to keep pushing forward? #TevaPharm #TevaCareers

What’s driving the business landscape in strategic partnerships and external collaborations to accelerate delivery of innovative therapies to patients worldwide? Konstantina Katcheves, SVP Innovative Business Development at Teva, reveals the key trends that are shaping the field: https://ow.ly/v7Y150VfA6v #Tevapharm

International Women’s Day is around the corner, and we’re turning the spotlight on inclusion! Did you know that a feeling of belonging increases employee job performance by 56%? And that creating an inclusive environment leads to a 75% reduction in sick days and a 50% drop in turnover? Stats like these show that fostering an environment where everyone feels heard and valued is not only the right thing to do; it also makes complete business sense. Want to hear more? Check out what these women leaders from across Teva’s commercial units had to say. 👇 Ready to make an impact? Explore our career opportunities: https://ow.ly/JoZx50VbJxb *Statistics sourced here: https://ow.ly/EnfV50VbJx9. Please note that data may change over time. Michal Rendler Wendy Logan Vanina Faillace #Tevapharm

Teva is using AI to develop digital biomarkers for conditions including schizophrenia and neurodegenerative diseases and accelerate clinical trial processes to get medicines to patients faster. Meet the people who are developing some of the most advanced and potentially game-changing technologies in healthcare today: https://ow.ly/CxmM50VaSjF #Tevapharm

One-way ticket or a return? ✈️ Meet Teva’s boomerang employees! Sharon Biran, Professional Assistant, was drawn back by Teva’s culture of growth. For Amy Melchior, Director Medical Writing, the strong sense of teamwork led her to rejoin. Both Sharon and Amy say being back at Teva felt just like coming home. 🏠 Dive into their stories here: https://ow.ly/ZORN50Va9HF Have you ever returned to a former workplace? What brought you back? #BoomerangEmployee #TevaPharm

"I was scared, but I had faith in myself." Melinda Voynova, Senior Chemist at Teva Bulgaria, remembers her first days as an intern at Teva. The beginning was challenging, and she wasn't sure how she would manage her new role and the responsibilities that came with it. However, her self-belief, along with the support of her colleagues and managers, helped her succeed. "I had excellent mentors who gave their all to help me learn" she says. Having supported herself through her chemical studies as a photo model, she then found herself on the other side of the lens, working on some of the world's most cutting-edge laboratory equipment. Eight years later, Melinda is grateful for the opportunities she's had to grow and develop her professional skills. "I would call my work 'a palette of colors'", she says, highlighting her diverse and dynamic nature of her role. Looking back on the early days of your career, what fears did you face when starting your first industry job? Share with us in the comments 💚 --- We are hiring at our advanced manufacturing facilities, join us >> https://ow.ly/8x9B50V90NK #TevaCareers #TevaPharm #TevaStories